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Interrelations between phosphorus, calcium, parathyroid hor-
mone, and renal phosphate excretion in response to an oral phos-
phorus load in normal and uremic dogs. This study evaluates the
sequential interactions between serum phosphorus, ionized cal-
cium, parathyroid hormone (PTH), and fractional and absolute
phosphate excretion following an oral phosphorus load (100 or
500 mg) in normal (N) and two groups of uremic dogs. One group
of uremic dogs (uremic-constant solute intake; U-CS!), main-
tained on a diet containing 1,500 mg of phosphorus daily, devel-
oped the adaptive increases in fractional phosphate excretion
and P1'H levels characteristic of uremia. A second group of ure-
mic dogs (uremic-proportional reduction of solute; U-PRS), in
which dietary phosphorus intake was reduced in proportion to
the reduction in GFR, exhibited normal fractional phosphate ex-
cretion and PTH values. After an oral phosphorus load, the rise
in serum phosphorus was greater in U-CSI than in N dogs but not
different than in U-PRS dogs. For any given increase in serum
phosphorus, the fall in serum ionized calcium was identical in N
and U-CS! dogs. The relationship was not significantly different
in U-PRS, but there was a suggestion of a greater fall in serum
ionized calcium for any given rise in serum phosphorus. The in-
crease in PTH associated with the decrease in serum ionized cal-
cium was greater, albeit not significantly, in U-CS! than in N
dogs, while the same decrease in serum ionized calcium elicited a
significantly smaller PTH increase in U-PRS than in N or U-CSI
dogs. The maximal tubular capacity for phosphate reabsorption
was significantly lower in U-CS! dogs than in either N-or U-PRS
animals. Finally, both groups of uremic dogs excreted signifi-
cantly less phosphorus than did the N dogs after the oral phos-
phorus load. Both uremic groups excreted significantly more
phosphorus per unit of functioning nephron mass than did the N
dogs. In conclusion, the phosphorus-calcium-PTH axis in the
uremic dog functions in an intact and appropriate manner, al-
though it does so at different levels of sensitivity, depending on
renal function and the preceding dietary phosphorus intake.
Interrelations entre phosphore, calcium, hormone para-
thyroIdienne et excretion rénale de phosphate en response a une
charge orale de phosphore chez le chien normal ou urèmique. Ce
travail évalue les interactions séquentielles entre Ia phosphor-
ernie Ia concentration serique de calcium ionisé, Ia concentration
circulante d'hormone parathyroldienne (PTH), et les excretions
fractionnelle et absolute de phosphate après une charge orale en
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phosphore (100 ou 500 mg) chez le chien normal (N) ou apparte-
nant a l'un des deux groupes urémiques. Un groupe de chiens
urémiques (urémique—apport constant de substances dissoutes:
U-CS!), maintenu a un régime contenant 1,500 mg de phosphore
par jour, développe une augmentation adaptative de les excre-
tions fractionnelle de phosphate et PTH caractéristique de
l'urémie. Un second groupe de chiens urémiques (urémique—
reduction proportionnelle de l'apport de substances dissoutes:
U-PRS), dans lequel l'apport quotidien de phosphore est réduit
en proportion de Ia reduction de GFR, a des valeurs normales de
les excretions fractionnelle de phosphate et de PTH. Après une
charge orale de phosphore l'augmentation de phosphorémie est
plus grande chez U-CSI que chez N mais pas differérente de U-
PRS. Pour une augmentation donnée de phosphoremie Ia chute
de serique de calcium ionese est identique chez N et U-CS!. La
relation n'est pas significativement differente chez U-PRS mais il
y a une possibilité d'une plus grande chute de phosphorémie
pour une augmentation donnée de phosphorémie pour une aug-
mentation donnée de phosphorémie. L'augmentation de PTH as-
sociée a Ia diminution de phosphoremie est plus grande, encore
que non significative, chez U-CS! que chez N alors que Ia méme
diminution de phosphorémie determine une augmentation de
P1'H significativement moindre chez N que chez U-CSI. La
capacité maximale de reabsorption de phosphate est signifi-
cativement inférieure chez U-CS! que chez N ou U-PRS. Enfin
les deux groupes de chiens urémiques excrètent signifi-
cativement moms de phosphate que N après une charge orale.
Les deux groupes urémiques excrètent significativement plus de
phosphate par unite de masse néphronique fonctionnelle que N.
En conclusion l'axe phosphore-calcium-PTH du chien urémique
fonctionne d'une facon complete et appropriée bien qu'à dif-
ferents niveaux de sensibilité dèpendants de Ia fonction rénale et
de l'apport alimentaire antérieur de phosphore.
In any subject maintaining phosphorus balance,
renal excretion of phosphorus is equal to the
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amount of phosphorus absorbed from the gastroin-
testinal tract. External balance for phosphorus is
maintained under conditions not only of normal but
of markedly reduced renal function as well [1—4].
Since in uremia there is only a minor impairment of
gastrointestinal phosphorus absorption [5], the con-
tinued maintenance of phosphorus balance requires
an increase in phosphate excretion per nephron (or
in physiologic terms, in fractional excretion of
phosphate, FEB04) each time the glomerular filtra-
tion rate (GFR) falls [1—4]. A progressive rise in the
level of circulating parathyroid hormone (PTH) typ-
ically accompanies the increase in FEB04 [6]. Al-
though this hypothesis has recently been challenged
[7], this hyperparathyroidism presumably plays a
role in the rise in FEB04, thereby facilitating the ex-
cretion of ingested phosphorous despite the pres-
ence of a diminished renal mass.
The need for an ever-increasing FEB04 as renal
function declines can be obviated by reducing diet-
ary phosphorus in exact proportion to the fall in gb-
merular filtration rate [8, 9]. That this dietary regi-
men is associated with the maintenance of normal
PTH levels over a period of many months [10] em-
phasizes the role of phosphorus in the genesis of
uremic hyperparathyroidism and suggests a causal
relationship between parathyroid status and phos-
phate excretion.
All evidence suggests that serum ionized calcium
concentration is the primary determinant of PTH
secretion [11—14]. Changes in serum phosphorus
concentrations per se affect secretion indirectly be-
cause of reciprocal changes in serum calcium con-
centrations. Both i.v. infusion [13, 15] and oral in-
gestion [6. 14] of phosphorus result in a decrease in
ionized calcium concentration, which, in turn, stim-
ulates PTH secretion. The quantitative inter-
relations between the increase in phosphorus con-
centration, the decrease in calcium concentration,
and the increase in PTH secretion following an oral
phosphorus challenge have been only partially de-
fined in normal animals and are virtually unexplored
in the uremic state.
The present experiments were performed to eval-
uate further the phosphorus-calcium-PTH axis in
uremia as well as to examine their interactions on
phosphate excretion in normal and uremic dogs.
Methods
Thirty-six experiments were performed on 18
adult female mongrel dogs, each weighing between
12 and 22 kg. The dogs were divided into three ex-
perimental groups. One group included six animals
with normal renal function. The remaining 12 ani-
mals were made uremic by ligation of the majority
of the branches of the left renal artery and removal
of the right kidney. No uremic animals were studied
earlier than 4 weeks after surgery.
The six normal dogs and six of the uremic dogs,
designated uremic-constant solute intake (U-CS!),
were maintained on a diet of Wayne dog meal
throughout the study that supplied a daily phos-
phorus intake of 1,500 mg. The remaining six ure-
mic dogs received 400 g of a fibrin-base low phos-
phorus diet (ICN Pharmaceuticals, Cleveland, Oh.)
daily to which neutral sodium phosphate was added
in an amount equal to 1,500 mg times the ratio of
postsurgery GFRlpresurgery GFR. All other so-
lutes were kept constant. (Calcium content of
Wayne dog meal and low phosphorus diet was 2,100
and 1,700 mg/day, respectively. Magnesium content
of these diets was 180 and 240 mglday, respective-
ly.) Postsurgery GFR was determined within 3
days following operation. Phosphorus intake there-
by was reduced in exact proportion to the measured
reduction in GFR. This group is designated uremic-
proportional reduction of solute (U-PRS). Body
weight in all dogs in each group remained stable
throughout the study.
On the day of the experiment, the animals were
studied while they were in the unanesthetized state,
standing in a supporting sling, after a 15-hr fast.
They had free access to water until the time of the
experiment. A urinary catheter was inserted into
the bladder for quantitative urine collection.
Venous catheters were placed in the inferior vena
cava through a hind limb vein for infusion and blood
sampling. After an injection of a priming dose of
creatinine was given, a solution of 2.5% dextrose in
water containing creatinine was infused at a rate of
2 mI/mm in normal dogs and at a rate of 0.3 mI/mm
in uremic dogs. Glycosuria was not observed in any
animal throughout the experimental procedure.
After a 60-mm period of equilibration had lapsed,
three 20-mm control clearance periods were ob-
tained. Thereafter, either 100 or 500 mg of phos-
phorus was administered by orogastric tube as a
neutral sodium phosphate solution in a volume of 50
ml. Each dog was studied twice, once with each
dose of phosphorus. Immediately after the 50 ml of
phosphorus was administered, five 1-hr experimen-
tal clearance periods were obtained. At the end of
each period, the bladder was washed with 30 ml of
sterile water to ensure complete urine collection. At
the midpoint of each period, a sample of blood was
collected anaerobically. Phosphate and creatinine
Phosphorus horn eostasis in uremia 209
were measured in the urine and blood by a modified
autoanal yzer method (Technicon AutoAnalyzer II).
Serum ionized calcium concentration was deter-
mined with a flow-through electrode system (Orion
Biomedical, model SS-20). Serum parathyroid hor-
mone was quantitated by radioimmunoassay with
antiserum CH-7l at a final dilution of 1: 125,000.
This antiserum cross reacts with intact hormone as
well as with NH2- and COOH-terminal fragments.
All samples were measured in duplicate at two
widely varying dilutions. The coefficient of varia-
tion of replicate samples was 9%; assays showing a
larger variation were repeated. PTH levels are re-
ported in arbitrary units (p1-eq/mI), relating the po-
tency of the test serum to that of a standard hyper-
parathyroid serum sample obtained from a dog with
experimentally induced chronic renal failure [6, 161.
Data are expressed as means SEM. Statistical
analyses were performed with standard programs
for linear regression, student's t tests for unpaired
data, and one-way analysis of variance on a Wang
700 calculator.
Results
The mean value for GFR was 68 mI/mm in nor-
mal, 13 mI/mm in U-CS!. and 14.5 mI/mm in U-PRS
dogs. This experimental nephron reduction is a re-
producible model of experimental uremia that is as-
sociated with the typical development of secondary
hyperparathyroidism and renal osteodystrophy [3,
6, 101. Tables I and 2 outline the control data for the
three groups of dogs. With the exception of one set
of studies (normal dogs given 500 mg of phos-
phorus), no significant differences in control fasting
serum phosphorus were found. The ionized calcium
concentrations were significantly higher in the U-
PRS group than they were in either the normal or U-
CSI groups. In the U-CSI group, both FEB04 and
PTH levels were elevated. In contrast, in the U-
PRS dogs, both FEB04 and PTH levels were com-
parable to the values observed in the normal dogs.
The mean changes observed after 100 mg of oral
phosphorus are shown in Table 1. Serum phos-
phorus concentrations increased to the same extent
in each group, peaking in period two (1.5 hr after
ingestion) and returning toward normal by period
five. Serum ionized calcium concentrations decreased
in all three groups. The pattern of change from period
to period was the same except for period two in the
U-PRS group where there was a greater fall than
there was in either normal or U-CSI groups. Circu-
lating PTH levels increased in all groups, but the in-
crease was significantly higher during period one
and two in the U-CS! and U-PRS groups than it was
in normal dogs. The increase in FEB04 after inges-
tion of 100 mg of phosphorus was similar in the nor-
mal and U-CS! dogs. The increase in the U-PRS ani-
mals was significantly greater than it was in either
of the two other groups during periods two to five.
The mean directional changes observed after 500
mg of oral phosphorus were similar, but of greater
magnitude, to those elicited by 100 mg of oral phos-
Table 1. Mean changes from control values observed after 100mg of oral phosphorus in normal and uremic dogs
Changes from control
Period
Controlb 1 2 3 4 5
Serum phosphorus, mg/dl
Normal 5.0 0.4 0.7 0.2 1.4 0.1 I.! 0.1 0.8 0.1 0.7 0.1
U = CS! 4.9 0.2 0.8 0.2 1.3 0.2 1.1 0.2 0.9 0.2 0.8 0.2
U = PRS 5.1 0.4 1.0 0.3 1.4 0.3 1.3 0.3 1.1 0.2 1.0 0.2
Serum ionized calcium. mg/dI
Normal 4.90 0.07 —0.06 0.06 —0.12 0.02 —0.06 0.04 —0.08 0.04 —0.12 0.06
U = CS! 4.98 0.10 —0.12 0.04 —0.08 0.02 —0.06 0.04 —0.04 0.04 —0.10 0.04
U = PRS 5.44 0.04 —0.12 0.02 —0.22 0.02" —0.14 0.02 —0.10 0.02 —0.10 0.04
PTH, pi-Eqimi
Normal 62 9 1 2' 6 3" 7 5 10 3 10 6
U = CSI 509 50" 23 8 37 12 27 13 18 23 27 21
U =PRS 66 4 11 2 21 4 31 12 26 13 16 9
FE ,%
Normal 2 1 5 2 10 2 10 1 7 1 5 I
U=CSI 43 4±2 12 7±3 5±3 2±2
U = PRS II 4 12 4 26 5" 28 2" 26 4" 22 4"
Abbreviations used are: FE0, fractional excretion of phosphate; PTH, parathyroid hormone; U-CS!, uremic dogs on constant solute
intake; U-PRS, uremic dogs on proportional reduction of solute.
Control represents the absolute values prior to oral phosphorus load.
"P is 0.05 or less than in both other groups.
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Table 2. Mean changes from control values observed after 500 mg of oral phosphorus in normal and uremic dogs
Changes from control
Period
Control5 I 2 3 4 5
Serum phosphorus, mgldl
Normal 3.8 02d 1.5 0.3 3.5 0.4 2.5 0.2 2.0 0.2 1.5 0.3
U-CSI 4.9 0.3 1.8 0.3 5.1 0.3 4.5 0.4 3.9 0.4 3.4 0.4c
U-PRS 4.5 0.4 1.8 0.5 4.7 0.6 3.7 0.7 2.9 0.6 2.3 0.5
Serum ionized calcium, mgldl
Normal 4.96 0.08 —0.18 0.04 —0.36 0.04 —0.28 0.06 —0.20 0.06 0.04 0.04
U-CS! 5.06 0.08 —0.14 0.04 —0.50 0.04 —0.42 0.08 —0.36 0.08 —0.36 0.08c
U-PRS 5.64 0•14d —0.30 0.10 —0.66 0.16 —0.78 0.16c —0.72 0.I8 —0.70 0.18e
PTH, pJ-Eq/ml
Normal 75 5 20 8 59 15 61 15 34 7 22 4
U-CSI 524 37" 4 14 60 10 122 40 136 42 141 62
U-PRS 71 6 23 II 50 24 81 34 71 38 58 31
FE0,, %
Normal 3 2 10 2 31 4 29 3 23 4 IS 5
U-CS! 50 5" 14 3 29 4 26 2 29 6 31 10
U-PRS 8 5 20 5 52 5' 53 4" 48 3" 48 3"
Abbreviations are the same as in Table 1.
Control represents the absolute values prior to oral phosphorus load.
P is 0.02 or less than in normal dogs.
p is 0.05 or less than in other two groups.
phorus; these are shown in Table 2. The increase in creted above the baseline level of excretion record-
serum phosphorus concentration in the U-CS! ed during the control periods. On an absolute basis,
group was significantly greater than it was in normal the normal, U-CSI, and U-PRS dogs excreted the
dogs during periods three to five, but it was not dif- 100-mg phosphorus load similarly. Neither uremic
ferent from that of U-PRS dogs. Serum phosphorus group was able to handle the 500-mg phosphorus
concentrations in all dogs peaked during period two load when compared to the normal dogs. On a mg-
and then fell towards but never to normal. Except per-ml-GFR basis, both uremic groups demon-
for period five, serum ionized calcium concentra- strated a greater excretory capacity than did the
tions fell to the same degree in normal and U-CS! normal dogs.
groups. The U-PRS dogs had a greater fall in ion- The relationship between the increase in serum
ized calcium concentrations than did normal dogs phosphorus concentrations and the decrease in
during periods three to five. PTH levels increased to serum ionized calcium concentrations is depicted in
the same extent in each group. As with the 100-mg Figure 1 for the three groups of animals. The rela-
phosphorus load, the rise in FEB04 was similar in the tionship is linear in each group (normal, y = —0.01
normal and U-CS! dogs, while the U-PRS group + 0.lOx, r = 0.89; U-CS!, y = —0.01 + 0.l0x, r =
had a significantly greater increase than did either of 0.98; U-PRS, y = —0.12 + 0. 19x, r = 0.86). Statis-
these groups during periods two to five. tical comparison of the slopes of the three lines re-
For each group, Table 3 shows the cumulative veal no statistically significant difference. For every
5-hr excretion of the phosphorus load adminis- I mg/lOO ml rise in serum phosphorus concentration,
tered. This is the concentration of phosphorus ex- there was a 0.10 mg/100 ml fall in serum ionized cal-
Table 3. Cumulative 5-hr excretion of the phosphorus load administered in normal and uremic dogsa
l00mgof Soomgof
phosphorus phosphorus
Normal U-CSI U-PRS Normal U-CS! U-PRS
mg 97 40 24 10 66 14 300 25 135 13b 193 27"
mg/GFR 1.4 0.3 2.2 0.9 4.7 0.5" 4.3 0.5 12.4 1.4" 13.5 2.4"
a Abbreviations are the same as in Table 1.
bSignificantly different from normal group (P < 0.05 or less).
cium concentration in the normal and U-CSI dogs
and a 0.19 mg/100 ml fall in that of the U-PRS ani-
mals. The three groups together demonstrated a
0.13 mgIIOO ml fall in serum ionized calcium con-
centration for each I mg/l00 ml rise in serum phos-
phorus (v = —0.004 + 0.13x, r = 0.78).
Figure 2 shows the increase in PTH levels as a
function of the fall in serum ionized calcium con-
centrations for the three groups individually. In
each group, there was a significant reciprocal corre-
lation between the decreases in serum ionized cal-
cium concentrations and increases in serum PTH.
There was a tendency for a greater, albeit not signif-
icant, rise in PTH level per unit decrease in ionized
calcium concentration to occur in U-CSI than there
was for normal dogs over the range studied, On the
other hand, the same decrease in ionized calcium
concentration elicited a significantly smaller in-
crease in PTH levels in U-PRS dogs than it did in
either the normal or U-CS! animals (P < 0.02 and
0.01, respectively).
Figure 3 expresses the data from the present ex-
periments in the form of phosphate titration curves.
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Fig. 2. Relationship between the increase in circulating PTH lev-
els and the decrease in serum ionized calcium concentration fol-
lowing an oral phosphorus load of /00 and 500 ing. Each point
represents the mean value for all six dogs at a given time period
1.0 2.0 3.0 4.0 5.0 6.0 after oral phosphorus. The linear regression for the different
Serum phosphorus concentration, mg/dI
groups of dogs is: normal. y = —5.6 + 190x (r = 0.88); U-CSI.
v = 4.7 + 271x (r = 0.80); U-PRS y = 9.7 + 78x (r = 0.98).
Fig. 1. Relationship between the increase in serum phosphorus
concentrations and the concomitant decrease in seru,n ionized
calciu,n concentrations following an oral phosphorus load of /00
and 500 ,ng. Each point represents the mean value for all six
dogs at a given time period after oral phosphorus administration.
The linear regression is y = — 0.004 + 0. l3x (r = 0.78).
Phosphate excretion (UV04) normalized for GFR is
plotted as a function of serum phosphorus concen-
trations. Values were similar in the normal and U-
PRS groups. In the fasting state, at similar concen-
trations of serum phosphorus, UV4!GFR was sig-
nificantly higher (P < 0.00 1) in the U-CS! dogs than
they were in either normal or U-PRS dogs.
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Fig. 3. Phosphate excretion normalized for GFR plotted as a
function of serum phosphorus concentration. Each point repre-
sents the mean value for all six dogs during the control and ex-
perimental periods following 100 and 500 mg or oral phosphorus.
The linear regression for the different groups of dogs is: normal,
y = — 3.8 + .84x (r = 0.71); U-CS!, y = — 4.0 + l.20x(r = 0.99); U-PRS. y = — 5.5 + 1.24x (r = 0.96). The three
slopes are not significantly different from one.
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The tubular maximum for phosphate reabsorp-
tion (Tmo4IGFR) for each dog was derived as the
mean threshhold [18]. The normal and U-PRS dogs
had values of Tm04IGFR of 4.5 0.3 and
4.2 0.3 mgIlOO ml, respectively. The Tm4IGFR
of 3.3 0.2 mg!100 ml observed in the U-CSI ani-
mals was significantly lower.
Discussion
If phosphorus intake and enteric absorption re-
main constant as renal function declines, there is a
progressive increase in the fractional excretion of
phosphates, allowing for the continued maintenance
of external balance [1—4]. This maintenance of equal-
ity between intake and output of phosphorus is asso-
ciated with a progressive rise in PTH levels [6]. If
phosphorus intake is reduced in exact proportion to
the reduction in GFR as renal disease advances, the
need for an increase in the fractional excretion of
phosphate is obviated; and it has been found [8—10]
and confirmed in these studies that the PTH levels
remain within the normal range. These observations
have demonstrated an integral role for phosphorous
in the genesis of uremic hyperparathyroidism. The
data also suggest that the rise in circulating PTH
levels plays a central role in the increasing rate of
phosphorus excretion per nephron. The present ex-
periments evaluate the phosphorus-calcium-PTH
axis and the influence of perturbing the component
parts of this axis on renal phosphate excretion in
normal and uremic dogs.
Previous studies in cow, dog, and man have dem-
onstrated that the acute elevation of serum phos-
phorus concentration by i.v. infusion or oral inges-
tion of phosphorus will depress serum calcium re-
ciprocally and stimulate release of PTH. However,
a good quantitative correlation between the above
parameters in both the normal [13, 14] and uremic
[6, 15] state has not been shown. In the present ex-
periments, we have found a highly significant rela-
tionship between the increase in concentration of
serum phosphorus induced by oral phosphorus-
loading and the decrease in concentration of serum
ionized calcium over a wide range of changing
serum phosphorus concentrations. The observed
correlation between serum phosphorus concentra-
tion and ionized calcium concentration was identi-
cal in the normal and U-CSI dogs. Although the
relationship between serum phosphorus and ionized
calcium concentrations in the U-PRS group was not
significantly different from the normal and U-CSI
groups, there was a suggestion of a greater decrease
in ionized calcium concentration for any given in-
crease in phosphorus concentration (Fig. 1). This
may be due to the smaller increase in PTH levels in
this latter group, which is associated with equiva-
lent decreases in ionized calcium concentrations
(see below).
In the present studies, the responsiveness of the
parathyroid glands, as judged by increases in circu-
lating PTH levels, correlated closely with the de-
crease in serum ionized calcium concentrations but
differed in magnitude in the two uremic groups (Fig.
2). There was suggestive evidence of a greater rise
in PTH levels for any given decrease in serum ion-
ized calcium concentrations in the uremic hyper-
parathyroid (U-CSI) dogs than there was in the nor-
mal dogs. This tendency for an enhanced response
may be due to a larger cell mass present in the hy-
perparathyroid uremic dogs.
In contrast, the uremic euparathyroid (U-PRS)
animals had significantly less of a rise in PTH levels
for any similar decrease in serum ionized calcium
concentrations than did either the normal or U-CSI
groups. This blunted response may have been re-
lated to chronic understimulation of the parathyroid
glands in the U-PRS dogs caused by the proportion-
ately reduced concentration of phosphorus intake
and the elevated concentration of serum ionized
calcium.
It has been our experience that every uremic dog
treated with a proportional reduction of phospho-
rus intake develops a mild increase in concentra-
tion of serum ionized calcium. The pathogenesis
of this observation, however, is obscure. It is
known that the concentration of dietary phospho-
rus intake will in some way reciprocally modify
the concentration of serum calcium [17]. More-
over, the same observation can be made in uremic
dogs switched from a high to a proportionately
reduced phosphorus diet and then back to a nor-
mal diet (KAPLAN MA: Unpublished observation).
In these animals the increase in serum calcium
concentration occurs as early as 2 days after the
change in diet. Stool and urine samples show a
neutral phosphate balance, demonstrating that the
rise in serum calcium concentration is independent
of phosphorus depletion.
At similar fasting serum phosphorus concentra-
tions, the UV4/GFR was significantly higher in the
uremic hyperparathyroid (U-CSI) dogs in com-
parison with either normal or uremic euparathyroid
(U-PRS) animals (Fig. 3). The normal and uremic
euparathyroid (U-PRS) dogs had similar but signifi-
cantly higher TM4's/GFR than did the uremic hy-
perparathyroid (U-CSI) group.
The amount of phosphate in the urine is the dif-
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ference between filtered load and tubular reabsorp-
tion. Phosphaturia will not occur until Tm04/GFR
is surpassed. With a constant Tm04/GFR and an in-
creasing filtered load (serum phosphorus), filtered
load is the determinant of UV4/GFR. Conversely,
Tm04/GFR is the determinant of UV04/GFR with a
constant filtered load and a decreasing Tm4/GFR.
In the present experiments, both variables are
changing. With oral phosphorus, the normal and both
groups of uremic dogs quickly reach Tmru4/GFR
(Fig. 3).
Recently, it has been suggested that uremic para-
thyroidectomized dogs can maintain phosphorus
balance similarly to their nonparathyroidectomized
counterparts [7]. This is not surprising in light of the
present data. Parathyroidectomized dogs would be
expected to have a higher Tm04/GFR and to handle
their dietary phosphorus on a filtered load basis.
Overall 24-hr balance would be maintained as long
as phosphorus intake did not exceed the capabilities
of the filtered load. Fasting serum phosphorus con-
centration would be determined by the value of
Tm4/GFR and the balance between phosphorus
intake and the level of the filtered load. It would be
interesting to evaluate the response of uremic para-
thyroidectomized dogs to acute phosphorus loads
to see the magnitude of change of serum phospho-
rus concentration, ionized calcium concentration,
and fractional and absolute phosphate excretion.
A recent study has shown that a very high phos-
phorus intake in the normal dog can lead to sus-
tained increases in the level of PTH [17]. The
present study demonstrates the prolonged nature
of the hyperphosphatemia, hypocalcemia, and en-
hanced PTH secretion in the normal dog follow-
ing an oral phosphorus load of 500 mg. This se-
ries of events was of even greater magnitude and
duration in the uremic animals, underscoring the
critical role of phosphorus in the genesis of second-
ary hyperparathyroidism.
During the 5 hr following the oral phospho-
rus load, the normal dogs excreted 97% of the
100-mg and 60% of the 500-mg challenge. Both ure-
mic groups handled the 100-mg challenge similarly
to that in the normal dogs. In contrast, both uremic
groups excreted significantly less phosphorus than
did normal dogs after the 500-mg load despite great-
er hyperphosphatemia.
When excretion was evaluated per unit of func-
tioning nephron mass, a different pattern was ob-
served. The uremic animals, whether on constant
solute intake or proportional reduction of phos-
phorus, excreted significantly more phosphorus per
residual mass than did the normal dogs. This magni-
fled response of the uremic nephron occurred by a
combination of a greater filtered load and a de-
creased Tm04/GFR at high concentrations of serum
phosphorus.
In summary, the phosphorus-calcium-PTH axis
in the uremic dog functions in an intact and appro-
priate manner although it does so at different levels
of sensitivity, depending on the degree of renal in-
sufficiency and the preceding dietary phosphorus
intake. The uremic dog on constant solute intake
has a significantly lower Tm04/GFR than do either
the normal or uremic dog on proportional phos-
phorus reduction.
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